首页 › 基金 › Blue Water Life Science Advisors, LP › ADPT

Blue Water Life Science Advisors, LP 对 ADPT 的持仓历史

ADAPTIVE BIOTECHNOLOGIES COR · 医疗保健

Blue Water Life Science Advisors, LP 在 Q3 2026 的 13F 申报中披露持有 ADPT(ADAPTIVE BIOTECHNOLOGIES COR)1,010,145 股,市值约 US$29.2M,约占其申报组合的 11.60%,在其申报持仓中市值排名第 3 位。 Blue Water Life Science Advisors, LP 最近 13 个申报季度中有 12 个季度披露了 ADPT 持仓,最早可追溯至 Q3 2023。

最新持仓 (Q3 2026)1.01M 股
申报持仓市值$29.19M
组合权重11.60%
首次申报Q3 2023
最近变动持有
更新于2026-11-14

最后更新: 2026-11-14 · 来源: SEC EDGAR Form 13F-HR

Blue Water Life Science Advisors, LP 对 ADPT 的持仓演变

Blue Water Life Science Advisors, LP 于 Q3 2023 首次披露 ADPT 持仓:2,377,665 股(约 US$13.0M)。 该持仓在 Q3 2025 达到峰值 2,145,145 股,市值约 US$32.1M。 在 12 次申报中,Blue Water Life Science Advisors, LP 0 次增持、3 次减持、7 次保持不变。 最近一期申报(Q3 2026)显示持股 1,010,145 股、市值约 US$29.2M。 持仓曾出现大幅变动:Q4 2023 减持约 29% (随后一个季度股价下跌 34%)、Q1 2026 减持约 43% (随后一个季度股价上涨 55%)。

逐季持仓明细

季度股数金额变化
Q3 2023 2.38M $12.96M 新进
Q4 2023 1.69M $8.27M 减持
Q1 2024 1.69M $5.42M 持有
Q3 2024 2.15M $10.98M 新进
Q4 2024 2.15M $12.86M 持有
Q1 2025 2.15M $15.94M 持有
Q2 2025 2.15M $24.99M 持有
Q3 2025 2.15M $32.09M 持有
Q4 2025 1.77M $28.67M 减持
Q1 2026 1.01M $14.02M 减持
Q2 2026 1.01M $21.67M 持有
Q3 2026 1.01M $29.19M 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 ADPT 与 13F 数据

ADPT(ADAPTIVE BIOTECHNOLOGIES COR)属于医疗保健行业。我们追踪的基金中还有 56 只申报持有 ADPT,申报仓位最大的包括:维京环球投资 (US$643.4M), VIKING GLOBAL INVESTORS LP (US$643.4M), Aristotle Atlantic Partners, LLC (US$39.4M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 ADPT 的基金

查看 ADPT 的全部基金持有人 →

常见问题

How long has Blue Water Life Science Advisors, LP held ADPT?

Blue Water Life Science Advisors, LP has disclosed ADPT holdings in 12 of the last 13 reported quarters, going back to Q3 2023.

What is Blue Water Life Science Advisors, LP's current position in ADPT?

As of Q3 2026, Blue Water Life Science Advisors, LP holds 1.01M shares of ADPT (ADAPTIVE BIOTECHNOLOGIES COR), valued at $29.19M, representing 11.60% of its reported portfolio and ranking #3.

Has Blue Water Life Science Advisors, LP been buying or selling ADPT?

In the latest 13F filing (Q3 2026), Blue Water Life Science Advisors, LP held unchanged its position in ADPT. The position peaked in Q3 2025 at 2.15M shares.

Which other funds hold ADPT?

Other major institutional holders of ADPT include 维京环球投资, VIKING GLOBAL INVESTORS LP, Aristotle Atlantic Partners, LLC, among 56 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.